Product Information

RITONAVIR 100 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6067 per EA under NDC 65862068730. Its NADAC has been published 407 times since Nov 7, 2018.

FDA first approved this application on Sep 17, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RITONAVIR 100 MG TABLET

Ritonavir
$0.6067per EA

Strength

100 mg/1

NDC

65862068730

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

RITONAVIR

Approval Type

Generic (ANDA)

FDA Application

ANDA206614

FDA Approved

9/17/2018

TE Code

AB

On Market Since

9/17/2018

Pharmacological Classes

Breast Cancer Resistance Protein Inhibitors
Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inducers
Cytochrome P450 3A Inhibitor
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
HIV Protease Inhibitors
P-Glycoprotein Inhibitors
Protease Inhibitor
UDP Glucuronosyltransferases Inducers

Price Statistics

The NADAC for RITONAVIR 100 MG TABLET has been published 407 times since Nov 7, 2018, and over the history we have for it it has declined 87.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6067 per EA
All-time high$5.0234 (Nov 14, 2018)
All-time low$0.5881 (Nov 22, 2023)
52-week high$0.9626
52-week low$0.6067
Median price$1.0510
Average price$1.2801
Largest weekly change+47.1% (May 19, 2021)
Weeks tracked407
Tracking sinceNov 7, 2018

Price History

1W

-3.3%

1M

-3.3%

3M

-7.4%

6M

-13.2%

1Y

-37.0%

3Y

-42.2%

5Y

-58.8%

All

-87.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RITONAVIR 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RITONAVIR 100 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.6067 per EA (NDC 65862068730), effective Aug 19, 2026.

How has the price of RITONAVIR 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for RITONAVIR 100 MG TABLET has declined 87.9%. It has been tracked across 407 weekly CMS publications since Nov 7, 2018.

What are the highest and lowest recorded NADAC prices for RITONAVIR 100 MG TABLET?

Since Nov 7, 2018, the NADAC for RITONAVIR 100 MG TABLET has ranged from a low of $0.5881 (Nov 22, 2023) to a high of $5.0234 (Nov 14, 2018), with a median of $1.0510 per EA.

Are there cheaper alternatives to RITONAVIR 100 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RITONAVIR 100 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures RITONAVIR 100 MG TABLET?

RITONAVIR 100 MG TABLET (NDC 65862068730) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.